{"id":"NCT04349072","sponsor":"Bristol-Myers Squibb","briefTitle":"A Study to Evaluate Mavacamten in Adults With Symptomatic Obstructive HCM Who Are Eligible for Septal Reduction Therapy","officialTitle":"A Randomized, Double-blind, Placebo-controlled Study to Evaluate Mavacamten in Adults With Symptomatic Obstructive Hypertrophic Cardiomyopathy Who Are Eligible for Septal Reduction Therapy","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2020-07-06","primaryCompletion":"2022-02-07","completion":"2024-05-20","firstPosted":"2020-04-16","resultsPosted":"2023-03-07","lastUpdate":"2025-05-23"},"enrollment":112,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["HOCM, Hypertrophic Obstructive Cardiomyopathy"],"interventions":[{"type":"DRUG","name":"Mavacamten","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Drug: Mavacamten","type":"EXPERIMENTAL"},{"label":"Drug: Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"This is a randomized, double-blind, placebo-controlled, multi-center study in the United States (U.S.) that will evaluate the effect of mavacamten treatment on reducing the number of septal reduction therapy (SRT) procedures performed in subjects with symptomatic obstructive hypertrophic cardiomyopathy (oHCM \\[also known as HOCM\\]) who are eligible for SRT based on ACCF/AHA 2011 and/or ESC 2014 guidelines.","primaryOutcome":{"measure":"Composite of Decision to Proceed With Septal Reduction Therapy (SRT) and SRT Guideline Eligible at Week 16","timeFrame":"Week 16","effectByArm":[{"arm":"Mavacamten","deltaMin":10,"sd":null},{"arm":"Placebo to Mavacamten","deltaMin":43,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.0001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":7},"locations":{"siteCount":21,"countries":["United States"]},"refs":{"pmids":["39556124","39254622","39221824","37639243","36335645","36335531","35798455","34081217","34038706"],"seeAlso":["https://www.bms.com/researchers-and-partners/clinical-trials-and-research.html","http://www.BMSClinicalTrials.com"]},"adverseEventsSummary":{"seriousAny":{"events":21,"n":108},"commonTop":["COVID-19","Fatigue","Dizziness","Palpitations","Urinary tract infection"]}}